欢迎来到范德生物BIOFOUNT
范德生物中国

中文范德生物中文语言

范德生物产品购买购物车
0
搜索
MPT0B392_1346169-92-3_产品详情
1346169-92-3
  • names:

    MPT0B392

  • CAS号:

    1346169-92-3

    MDL Number:
  • MF(分子式): C19H20N2O6S MW(分子量): 404.44
  • EINECS: Reaxys Number:
  • Pubchem ID: Brand:
MPT0B392
货品编码 规格 纯度 价格 (¥) 现价(¥) 特价(¥) 库存描述 数量 总计 (¥)
快速询价
收起
你想询价的产品
请准确填写您的联系方式,以便为您提供最好的服务。
中文别名
英文别名
CAS号 1346169-92-3
Inchi
InchiKey
分子式 Formula C19H20N2O6S
分子量 Molecular Weight 404.44
溶解度Solubility
性状
储藏条件 Storage conditions 请根据产品建议的存储条件进行存储,Please store the product under the recommended condition sin the description.
MPT0B392(CAS:1346169-92-3)实验注意事项:
1.实验前需戴好防护眼镜,穿戴防护服和口罩,佩戴手套,避免与皮肤接触。
2.实验过程中如遇到有毒或者刺激性物质及有害物质产生,必要时实验操作需要手套箱内完成以免对实验人员造成伤害
3.实验后产生的废弃物需分类存储,并交于专业生物废气物处理公司处理,以免造成环境污染Experimental considerations:
1. Wear protective glasses, protective clothing and masks, gloves, and avoid contact with the skin during the experiment.
2. The waste generated after the experiment needs to be stored separately, and handed over to a professional biological waste gas treatment company to avoid environmental pollution.
产品说明 MPT0B392 是一种有效的口服活性的喹啉衍生物,作用于c-Jun N末端激酶 (JNK)和apoptosis的激活剂
IntroductionMPT0B392, an orally active quinoline derivative, inducesc-Jun N-terminal kinase (JNK)activation, leading toapoptosis. MPT0B392 inhibits tubulin polymerization and triggers induction of the mitotic arrest, followed by mitochondrial membrane potential loss andcaspasescleavage by activation of JNK and ultimately leads to apoptosis. MPT0B392 is demonstrated to be a novelmicrotubule-depolymerizingagent and enhances the cytotoxicity of sirolimus in sirolimus-resistant acute leukemic cells and the multidrug resistant cell line[1].
Application1
Application2
Application3
MPT0B392 是一种有效的口服活性的喹啉衍生物,作用于c-Jun N末端激酶 (JNK)和apoptosis的激活剂。MPT0B392 抑制微管蛋白聚合,通过激活 JNK 诱导细胞有丝分裂停滞,线粒体膜电位丧失和caspases裂解,最终导致细胞凋亡。MPT0B392 是一种有效的新型微管解聚剂,可增强西罗莫司对耐药急性白血病细胞和多药耐药细胞系的细胞毒性。MPT0B392, an orally active quinoline derivative, inducesc-Jun N-terminal kinase (JNK)activation, leading toapoptosis. MPT0B392 inhibits tubulin polymerization and triggers induction of the mitotic arrest, followed by mitochondrial membrane potential loss andcaspasescleavage by activation of JNK and ultimately leads to apoptosis. MPT0B392 is demonstrated to be a novelmicrotubule-depolymerizingagent and enhances the cytotoxicity of sirolimus in sirolimus-resistant acute leukemic cells and the multidrug resistant cell line[1].
警示图
危险性
危险性警示
安全声明
安全防护
备注
【1】.Chao MW, et al. An oral quinoline derivative, MPT0B392, causes leukemic cells mitotic arrest and overcomes drug resistant cancer cells. Oncotarget. 2017 Apr,8(17):27772-27785.
    对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
        新闻
        抱歉,暂无数据!
        My title page contents